Oxaliplatin, ATR inhibitor and anti-PD-1 antibody combination therapy controls colon carcinoma growth, induces local and systemic changes in the immune compartment, and protects ag... by Henri-Alexandre Michaud, Nathalie Bonnefoy, François Quenet, Julien Faget, Diego Tosi, Celine Gongora, Olivia Sgarbura, Alexandra Fauvre, Chiara Ursino, Veronique Garambois, Elodie Culerier, Louis-Antoine Milazzo, Nadia Vezzio-Vié, Laura Jeanson, Candice Marchive, Augusto Faria Andrade, Eve Combes, Salima Atis, Gérald Lossaint, Lakhdar Khellaf, Ileana Corbeau, Nadine Houede

Get full text